I think if the deal is good for shareholders and the execs they will do a deal. But it will have to be something they feel is equal to the drugs potential. But lets face it they are in the drivers seat. They have two choices they either get a nice deal and give a larger player access to the drugs potential or they take it to market themselves and give some larger players a big headache. They will have no problems finding cash to market it with the results already. I feel they are already working on a deal with a larger player right now.
Market Data 
Markets 
AI
